MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)
MLTX social buzz surges on FDA approval hopes and buyout speculation, overshadowing trial setbacks. Short squeeze chatter adds to the volatile mix.
About MoonLake Immunotherapeutics Class A Ordinary Shares
MoonLake Immunotherapeutics is a biotechnology company developing novel immunotherapies.
MoonLake Immunotherapeutics Class A Ordinary Shares uses the ticker $MLTX for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) social dominance is up 80.94% from the previous week.
- MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) creators is up 14.73% from the previous week.
- MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) engagements is up 94.97% from the previous week.
- MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) mentions is up 23.53% from the previous week.
- MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) posts created is up 108.33% from the previous week.
Price: $15.80
Price 24-Hour Time-Series Raw Data
Current price action is driven by speculation of a potential buyout or short squeeze and positive anticipation of FDA approval, which are currently outweighing negative clinical trial results and insider selling, despite a recent downgrade from Goldman Sachs.
24-Hour: 1.72% 7-Day: 3.11% 30-Day: -5.91%
1-Year High: $62 on 2025-09-26
1-Year Low: $6.20 on 2025-09-29
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) is currently AltRank #247 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] +15
[--] Months: [---] [----]
[--] Year: [---] [----]
1-Year High: [-----] on 2026-02-04
1-Year Low: [--] on 2025-09-29
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2026-01-08
1-Year Low: [--] on 2025-12-30
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [------] +95%
[--] Month: [-------] -62%
[--] Months: [---------] +90%
[--] Year: [---------] +190%
1-Year High: [-------] on 2025-09-29
1-Year Low: [---] on 2025-04-18
Engagements by network (24h): News: [--] YouTube: [--] TikTok: [--] X: [------] Reddit: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +24%
[--] Month: [---] -46%
[--] Months: [-----] +76%
[--] Year: [-----] +170%
1-Year High: [---] on 2026-01-09
1-Year Low: [--] on 2025-04-18
Mentions by network (24h): News: [--] YouTube: [--] TikTok: [--] X: [--] Reddit: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) in the last [--] hours which is down 50% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] +15%
[--] Month: [---] -39%
[--] Months: [-----] +8.20%
[--] Year: [-----] +199%
1-Year High: [---] on 2026-01-09
1-Year Low: [--] on 2025-04-19
The most influential creators that mention MoonLake Immunotherapeutics Class A Ordinary Shares in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | [--] | [------] | [--] | [-----] |
| @RNAiAnalyst | [--] | [------] | [--] | [---] |
| @Andre_AGTC | [--] | [-----] | [--] | [---] |
| @rynltmymy873300 | [--] | [--] | [--] | [---] |
| @ayasalmny | [--] | [--] | [--] | [---] |
| @jsm1sa | [--] | [---] | [--] | [---] |
| @Biotekster | [--] | [---] | [--] | [---] |
| @Ellie18153 | [--] | [--] | [--] | [--] |
| @David_Tonkinn | [--] | [--] | [--] | [--] |
| @OptionsAlertsAi | [--] | [---] | [--] | [--] |
Sentiment: 46%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 46%
Daily Average: 74%
[--] Week: 33% -34%
[--] Month: 50% -18%
[--] Months: 50% -42%
[--] Year: 50% +14%
1-Year High: 100% on 2025-02-24
1-Year Low: 20% on 2025-04-29
Most Supportive Themes:
- Positive FDA Approval Anticipation: (30%) Optimism surrounding an upcoming FDA decision is driving positive sentiment and investor interest.
- Potential Buyout Speculation: (30%) Market participants are discussing the possibility of a company acquisition, which could lead to a significant price increase.
- Short Squeeze Opportunity: (25%) Social media buzz suggests a potential short squeeze, attracting traders looking for rapid gains.
Most Critical Themes:
- Negative Clinical Trial Results: (15%) Recent trial data has been unfavorable, raising concerns about the company's drug development pipeline.
- Insider Selling: (10%) A significant insider sale has been noted, which can be interpreted as a negative signal by the market.
Social Dominance: 0.00578%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00578%
Daily Average: 0.012%
[--] Week: 0.00579% +0.00259%
[--] Month: 0.014% -0.031%
[--] Months: 0.014% +0.0047%
[--] Year: 0.014% +0.0093%
1-Year High: 0.10% on 2026-01-09
1-Year Low: 0.0025% on 2025-04-18
Market Dominance: 0.00127%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00127%
Daily Average: 0%
1-Year High: 0.089% on 2025-03-27
1-Year Low: 0.00049% on 2025-09-29
Market Cap: $1,117,263,514
Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,117,263,514
Daily Average: $2,129,384,958
[--] Week: $1,110,887,248 +0.40%
[--] Month: $1,117,263,514 -5.90%
[--] Months: $1,117,263,514 -68%
[--] Year: $1,117,263,514 -59%
1-Year High: $3,936,451,910 on 2025-09-26
1-Year Low: $396,566,255 on 2025-09-29
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing